|
Q2 FY2027
As of Jul 31, 2026
|
Q1 FY2027
As of Apr 30, 2026
|
Q4 FY2026
As of Jan 31, 2026
|
Q3 FY2026
As of Oct 31, 2025
|
Q2 FY2026
As of Jul 31, 2025
|
Q1 FY2026
As of Apr 30, 2025
|
Q4 FY2025
As of Jan 31, 2025
|
Q3 FY2025
As of Oct 31, 2024
|
Q2 FY2025
As of Jul 31, 2024
|
Q1 FY2025
As of Apr 30, 2024
|
Q4 FY2024
As of Jan 31, 2024
|
Q3 FY2024
As of Oct 31, 2023
|
Q2 FY2024
As of Jul 31, 2023
|
Q1 FY2024
As of Apr 30, 2023
|
Q4 FY2023
As of Jan 31, 2023
|
Q3 FY2023
As of Oct 31, 2022
|
Q2 FY2023
As of Jul 31, 2022
|
Q1 FY2023
As of Apr 30, 2022
|
Q4 FY2022
As of Jan 31, 2022
|
Q3 FY2022
As of Oct 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Short-term investments | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Deferred commissions | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Operating lease right-of-use assets, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Deferred commissions, non-current | ||||||||||||||||||||
| Deferred tax assets | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Other assets, non-current | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' DEFICIT | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable, accrued expenses and other current liabilities | ||||||||||||||||||||
| Accrued compensation and benefits | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Debt, net, current | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Debt, net, non-current | ||||||||||||||||||||
| Operating lease liabilities, non-current | ||||||||||||||||||||
| Other liabilities, non-current | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Series A convertible preferred stock, par value of $0.0001 per share; 500 shares authorized, issued and outstanding as of July 31 and January 31, 2026 | ||||||||||||||||||||
| Stockholders' deficit: | ||||||||||||||||||||
| Class A common stock, par value $0.0001 per share; 1,000,000 shares authorized; 137,201 and 140,911 shares issued and outstanding as of July 31 and January 31, 2026, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders' deficit | ||||||||||||||||||||
| Total liabilities, convertible preferred stock and stockholders' deficit | ||||||||||||||||||||
Loading...
